
IAS──Integrating Image, Genome, Molecular, Flow Cytometry,
and Mass Spectrometry
Collaborate on research data in a single cloud. Accelerate remote collaborative research and improve reproducibility and analysis efficiency.
Research and development, quality control, diagnostics, and testing utilize various distinct data formats.
We provide an integrated analysis system that supports the entire workflow by accommodating and centrally managing the specialized data formats used in each field.
The Strengths of IAS
- Multimodal Integration: Cross-analyze image, genomic, protein, molecular, and flow cytometry data
- Cloud Collaboration: Securely conduct joint research across sites and institutions
- Reproducibility and Efficiency: Reduce manual work with standardized pipelines
- Trust and Proven Track Record: Continued adoption and validation by pharmaceutical companies and research institutions
The Value of IAS
- For Researchers: High-precision analysis even outside your specialty, with intuitive UI and standardized workflows
- For Pharmaceutical Companies: Accelerate decision-making with cross-functional data, from drug discovery to preclinical and clinical stages
- For Partners: Proven through scalable architecture and international collaborative research
Connecting Fragmented Data
R&D, quality control, diagnostics and testing use a variety of different data formats.
We provide integrated analysis systems that support the entire workflow by supporting and centrally managing the specialized data formats used in each field.
Providing the Latest Technology

We always provide the latest version of our web system.
We also provide cutting-edge technologies such as generative AI, Web 3.0, blockchain, and proprietary AI algorithms as a means to achieve your goals.
Target Areas

Life Science
Pathology


Material Seience
Semicondutor

New Information
2024年7月24日
ImageJ & Image Analysis Individual Consultation Webinar
This seminar covers basic usage of ImageJ, an open source image analysis software for beginners, and IAS, a cl
2024年7月24日






